Features

Campaigns 50 celebrity healthcare endorsements

50 celebrity healthcare endorsements

Here's Jon Bon Jovi for Advil, Arnold Palmer for Xarelto and 48 more past and present celebrity endorsements of drugs, healthcare products and disease awareness campaigns.

Campaigns 15 unexpected Twitter responses to the "Who Pneu?" campaign

15 unexpected Twitter responses to the "Who Pneu?" campaign

Celebrity success or fail? Here's what the American Lung Association, Pfizer and Tim Daly likely did not see coming when they joined forces to raise awareness about pneumococcal pneumonia.

Campaigns The best and worst celebrity pharma moments

The best and worst celebrity pharma moments

Heaven knows the industry is itself to blame for some of the dopier recurring imagery in its DTC spots, like models clad in white linen riding horses on deserted stretches of beach.

Campaigns Celebrity drug ads: Opportunity or PR disaster?

Celebrity drug ads: Opportunity or PR disaster?

Tapping celebrities for brand or awareness campaigns ensures a high degree of attention, but such arrangements come with concerns that "regular" ones do not.

Agency Medical Advertising Hall of Fame inductees of 2016

Medical Advertising Hall of Fame inductees of 2016

A pharma research forefather. An agency builder. A "guy you wanted in the room." These Medical Advertising Hall of Fame inductees are a professionally diverse and richly worthy trio.

Payer/Managed Markets With PCSK9s, payers say, 'Let the market decide'

With PCSK9s, payers say, 'Let the market decide'

It's possible that payers won't prove the wild card in the PCSK9 derby. Instead, physician preference may do more to shape the market and maybe even force payers' hands.

Commercial Medicines360 CEO battles for IUD access

Medicines360 CEO battles for IUD access

Prior to Medicines360's arrival on the scene, there were only three IUDs on the market. The lack of competition drove prices sky-high.

Pipeline

Top 25 metabolic products, 2014-2015

Sanofi is the category leader. Its product, Lantus Solostar, brought in $5.27 billion in US sales between October 2014 and September 2015.

Pipeline Diabetes R&D narrows in on glycemic control

Diabetes R&D narrows in on glycemic control

New entrants in the type 2 diabetes treatment market share a similar goal: To solve patients' constant struggle with glycemic control.


The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.